Eric Roy Pettipher
11Patents
6h-index
12Co-inventors
63Inventor score
Filing activity: Jul 13, 1993 → Oct 7, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7582672B2 | Compounds for the treatment of CRTH2-mediated diseases and conditions | Chemistry; Metallurgy | 19 | Expired |
| US7750027B2 | Compounds having CRTH2 antagonist activity | Chemistry; Metallurgy | 17 | Active |
| US8563536B2 | Compounds having CRTH2 antagonist activity | Chemistry; Metallurgy | 8 | Active |
| US7919512B2 | Compounds having CRTH2 antagonist activity | Chemistry; Metallurgy | 8 | Active |
| US8198314B2 | Treatment of CRTH2-mediated diseases and conditions | Chemistry; Metallurgy | 6 | Active |
| US8163936B2 | Treatment of CRTH2-mediated diseases and conditions | Chemistry; Metallurgy | 6 | Active |
| US8314257B2 | Treatment of CRTH2-mediated diseases and conditions | Chemistry; Metallurgy | 6 | Active |
| US8163931B2 | Treatment of CRTH2-mediated diseases and conditions | Chemistry; Metallurgy | 6 | Active |
| US8536158B2 | Compounds having CRTH2 antagonist activity | Chemistry; Metallurgy | 6 | Active |
| US8980927B2 | Compounds having CRTH2 antagonist activity | Chemistry; Metallurgy | 3 | Active |
| US5482944A | Pyrimidones and imidazolinones for treatment of shock | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.